Cumberland Pharmaceuticals Inc.;Vanderbilt University
发明人:
Leo PAVLIV,Bryan VOSS,James West,Erica Carrier
申请号：
US16752933
公开号：
US20200155512A1
申请日:
2020.01.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
